DBV Technologies ADR’s recent filing unveils that its Chief Medical Officer Mohideen Pharis unloaded Company’s shares for reported $898.0 on May 24 ’24. In the deal valued at $1.36 per share,660 shares were sold. As a result of this transaction, Mohideen Pharis now holds 81,152 shares worth roughly $81963.52.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Mohideen Pharis sold 382 shares, generating $527 in total proceeds. Upon selling the shares at $1.38, the Chief Medical Officer now owns 81,812 shares.
Before that, Tasse Daniel bought 17,094 shares. DBV Technologies ADR shares valued at $14,188 were divested by the CHIEF EXECUTIVE OFFICER at a price of $0.83 per share. As a result of the transaction, Tasse Daniel now holds 17,094 shares, worth roughly $17264.94.
Societe Generale upgraded its DBV Technologies ADR [DBVT] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Goldman’s analysts, who decreased its forecast for the stock in mid December from “a Neutral” to “a Sell”. Goldman also remained covering DBVT and has decreased its forecast on May 10, 2022 with a “Neutral” recommendation from previously “Buy” rating. Societe Generale revised its rating on September 14, 2021. It rated DBVT as “a Buy” which previously was an “a Hold”.
Price Performance Review of DBVT
On Friday, DBV Technologies ADR [NASDAQ:DBVT] saw its stock fall -10.93% to $1.01. Over the last five days, the stock has lost -9.82%. DBV Technologies ADR shares have fallen nearly -47.00% since the year began. Nevertheless, the stocks have fallen -73.28% over the past one year. While a 52-week high of $4.52 was reached on 01/02/24, a 52-week low of $0.84 was recorded on 05/13/24. SMA at 50 days reached $1.3042, while 200 days put it at $1.8499. A total of 0.89 million shares were traded, compared to the trading of 0.12 million shares in the previous session.
Levels Of Support And Resistance For DBVT Stock
The 24-hour chart illustrates a support level at 0.9052, which if violated will result in even more drops to 0.8004. On the upside, there is a resistance level at 1.1096. A further resistance level may holdings at 1.2092. The Relative Strength Index (RSI) on the 14-day chart is 31.56, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0702, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 75.21%. Stochastics %K at 40.73% indicates the stock is a holding.
